Solesence, Inc. Common Stock (SLSN) Financial Ratios
4 years of historical data (2021–2024) · Consumer Defensive · Household & Personal Products
EV/EBITDA
↓
17.42
↓-66% vs avg
5yr avg: 50.92
30Y Low28.5·High73.4
P/FCF
N/A
—
5yr avg: 463.03
P/B Ratio
↓
5.66
↓-65% vs avg
5yr avg: 15.95
30Y Low9.8·High27.7
ROE
↑
50.3%
↓+368% vs avg
5yr avg: -18.7%
30Y Low-116%·High50%
Debt/EBITDA
↓
2.52
↓-32% vs avg
5yr avg: 3.71
30Y Low2.5·High4.9
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
SLSN Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Solesence, Inc. Common Stock trades at 18.6x earnings, 70% below its 5-year average of 61.4x, sitting at the 0th percentile of its historical range. This is roughly in line with the Consumer Defensive sector median P/E of 19.4x.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Market Cap | $92M | $159M | $30M | $56M | $207M |
| Enterprise Value | $106M | $173M | $49M | $71M | $221M |
| P/E Ratio → | 18.57 | 34.86 | — | — | 88.00 |
| P/S Ratio | 1.75 | 3.03 | 0.80 | 1.49 | 7.02 |
| P/B Ratio | 5.66 | 10.62 | 15.63 | 9.83 | 27.73 |
| P/FCF | — | — | — | — | 463.03 |
| P/OCF | 46.52 | 80.50 | — | — | 89.17 |
P/E links to full P/E history page with 30-year chart
SLSN EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
Solesence, Inc. Common Stock's enterprise value stands at 17.4x EBITDA, 66% below its 5-year average of 50.9x. The Consumer Defensive sector median is 11.3x, placing the stock at a 54% premium on an enterprise-value basis.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| EV / Revenue | — | 3.30 | 1.32 | 1.91 | 7.50 |
| EV / EBITDA | 17.42 | 28.47 | — | — | 73.37 |
| EV / EBIT | 20.57 | 33.62 | — | — | 62.96 |
| EV / FCF | — | — | — | — | 494.56 |
SLSN Profitability
Margins and return-on-capital ratios measuring operating efficiency
Solesence, Inc. Common Stock earns an operating margin of 9.8%, above the Consumer Defensive sector average of 1.1%. Operating margins have expanded from -6.1% to 9.8% over the past 3 years, signaling improving operational efficiency. Return on equity of 50.3% is exceptionally high — well above the sector median of 6.8%. ROIC of 15.3% represents solid returns on invested capital versus a sector median of 5.5%.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Gross Margin | 30.9% | 30.9% | 21.0% | 22.4% | 29.5% |
| Operating Margin | 9.8% | 9.8% | -9.5% | -6.1% | 8.7% |
| Net Profit Margin | 8.1% | 8.1% | -11.8% | -7.0% | 7.9% |
Return on Capital
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| ROE | 50.3% | 50.3% | -116.3% | -40.0% | 31.1% |
| ROA | 10.2% | 10.2% | -13.2% | -8.5% | 8.2% |
| ROIC | 15.3% | 15.3% | -12.4% | -7.9% | 8.9% |
| ROCE | 24.7% | 24.7% | -19.2% | -11.1% | 12.2% |
SLSN Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Solesence, Inc. Common Stock carries a Debt/EBITDA ratio of 2.5x, which is moderately leveraged (26% below the sector average of 3.4x). Net debt stands at $14M ($15M total debt minus $1M cash). Interest coverage of 7.7x is adequate, though a cyclical earnings downturn could tighten the margin of safety.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Debt / Equity | 1.02 | 1.02 | 11.18 | 3.20 | 1.98 |
| Debt / EBITDA | 2.52 | 2.52 | — | — | 4.90 |
| Net Debt / Equity | — | 0.93 | 10.27 | 2.82 | 1.89 |
| Net Debt / EBITDA | 2.29 | 2.29 | — | — | 4.68 |
| Debt / FCF | — | — | — | — | 31.53 |
| Interest Coverage | 7.66 | 7.66 | -4.23 | -5.91 | 2.22 |
SLSN Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.14x means Solesence, Inc. Common Stock can comfortably meet its short-term obligations, though there is limited excess liquidity. The quick ratio of 0.35x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has declined from 1.20x to 1.14x over the past 3 years.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Current Ratio | 1.14 | 1.14 | 1.05 | 1.20 | 1.58 |
| Quick Ratio | 0.35 | 0.35 | 0.40 | 0.56 | 0.75 |
| Cash Ratio | 0.05 | 0.05 | 0.11 | 0.16 | 0.09 |
| Asset Turnover | — | 1.05 | 1.13 | 1.11 | 1.04 |
| Inventory Turnover | 1.78 | 1.78 | 2.94 | 3.28 | 3.41 |
| Days Sales Outstanding | — | 33.95 | 33.93 | 46.30 | 48.75 |
SLSN Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Solesence, Inc. Common Stock does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business. The earnings yield of 5.4% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Earnings Yield | 5.4% | 2.9% | — | — | 1.1% |
| FCF Yield | — | — | — | — | 0.2% |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Shares Outstanding | — | $65M | $50M | $49M | $47M |
Peer Comparison
Compare SLSN with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 SLSNYou | $92M | 18.6 | 17.4 | — | 30.9% | 9.8% | 50.3% | 15.3% | 2.5 |
 SKIN | $118M | -5.7 | 7331.2 | 3.2 | 65.3% | -6.9% | -16.8% | -6.8% | 10519.4 |
 RVLV | $1B | 23.5 | 15.0 | 30.1 | 53.5% | 6.1% | 13.0% | 23.5% | 0.4 |
 ELF | $3B | 32.2 | 17.8 | 29.9 | 71.2% | 12.0% | 16.0% | 13.5% | 1.5 |
 COTY | $2B | -5.7 | 9.4 | 7.9 | 64.8% | 4.1% | -9.0% | 2.3% | 6.4 |
 IPAR | $3B | 17.9 | 11.3 | 15.8 | 63.6% | 18.2% | 16.5% | 18.6% | 0.8 |
 EL | $31B | -27.1 | 20.9 | 46.0 | 73.9% | 6.7% | -24.7% | 6.5% | 5.3 |
 ULTA | $24B | 20.5 | 5.3 | 22.6 | 39.1% | 39.1% | 43.6% | 87.9% | 0.5 |
 HIMS | $7B | 50.3 | 42.7 | 89.6 | 59.3% | 5.2% | 25.2% | 10.7% | 6.4 |
 MNST | $74B | 39.2 | 28.5 | 37.8 | 55.8% | 29.2% | 26.8% | 33.1% | — |
 KVYO | $5B | -143.3 | — | 25.2 | 74.7% | -5.5% | -2.8% | -22.2% | — |
| Consumer Defensive Median | — | 19.4 | 11.3 | 15.0 | 40.1% | 1.1% | 6.8% | 5.5% | 3.4 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 4 years · Updated daily
See SLSN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs SLSN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare SLSN vs SKIN
Side-by-side business, growth, and profitability comparison vs The Beauty Health Company.
Start ComparisonSLSN — Frequently Asked Questions
Quick answers to the most common questions about buying SLSN stock.
What is Solesence, Inc. Common Stock's P/E ratio?
Solesence, Inc. Common Stock's current P/E ratio is 18.6x. The historical average is 61.4x.
What is Solesence, Inc. Common Stock's EV/EBITDA?
Solesence, Inc. Common Stock's current EV/EBITDA is 17.4x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 50.9x.
What is Solesence, Inc. Common Stock's ROE?
Solesence, Inc. Common Stock's return on equity (ROE) is 50.3%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is -18.7%.
Is SLSN stock overvalued?
Based on historical data, Solesence, Inc. Common Stock is trading at a P/E of 18.6x. Compare with industry peers and growth rates for a complete picture.
What are Solesence, Inc. Common Stock's profit margins?
Solesence, Inc. Common Stock has 30.9% gross margin and 9.8% operating margin.
How much debt does Solesence, Inc. Common Stock have?
Solesence, Inc. Common Stock's Debt/EBITDA ratio is 2.5x, indicating moderate leverage. A ratio between 2-4x is manageable but warrants monitoring.